Artelo Biosciences, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementArtelo Biosciences, Inc. • April 9th, 2021 • Pharmaceutical preparations • New York
Artelo Biosciences, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows:
